Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

The biotech sector has long offered investors high-risk, high-reward stocks. While large players are making headlines, the ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

The total market value of ALL pharma and biotech companies is $4.6 trillion.

Also, don’t miss Celebrate Autumn, Cherish Memories, Fight Alzheimer’s — Online Rally Nov. 6! on the Redmond Patch calendar ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...

The U.S. has ceded its leadership in critical industries before. It must not do so with China and biotech now, writes the ...

Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.

Licensing remains a dominant model. The value of the licensing-out deals signed by Chinese biotech firms in the first half of ...